Flexion Therapeutics (FLXN) – Litigation
-
Flexion Therapeutics (FLXN) Announces Issuance of New U.S. Patent Covering FX201 Gene Therapy Product Candidate for Treatment of Osteoarthritis
-
Flexion Therapeutics (FLXN) Announces Two New Patents on Zilretta (FX006)
Back to FLXN Stock Lookup